Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Oliver Howes, MRCPsych, PhD
JCP
Insights
Emerging Treatments in Schizophrenia Video
February 17, 2022
In this video, 3 experts discuss the challenge of treating schizophrenia with the current medications, which target blockade of dopaminergic receptors, and explore 4 new medications (ulotaront, KarXT, CVL-231,...
Christoph U. Correll
,
Oliver Howes
,
Anissa Abi-Dargham
JCP
InfoPack
Emerging Treatments in Schizophrenia
February 15, 2022
Experts discuss the brain circuits involved in schizophrenia, the current medications, and new agents in phase 3 trials that do not directly block postsynaptic D2 receptors. Phase 2 data...
Christoph U. Correll
,
Anissa Abi-Dargham
,
Oliver Howes
JCP
Commentary
Treatment-Resistant Schizophrenia Guideline
March 5, 2019
Read expert commentary on guidelines for treatment-resistant schizophrenia (TRS) to make more informed treatment decisions.
Mark Olfson
,
John M. Kane
,
Ofer Agid
, et al
